Hyperrho Solution
Product Images NDC 13533-661
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Hyperrho (NDC 13533-661). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Grifols Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton (Carton)
This is a description of Rho(D) Immune Globulin (Human), specifically HyperRHO SID Mini-Dose containing 250 IU (50 mcg) of Rho(D) antibody in each single dose syringe. It is a sterile solution of immunoglobulin containing 15-18% protein stabilized with glycine and adjusted with sodium carbonate. It is treated with solvent/detergent and doesn't have any preservative or latex. The product is not for neonates and should not be administered intravenously. The package includes 10 single dose disposable syringes with attached needles. It should be stored at 2-8°C (36-46°F) and is not returnable for credit or exchange. The enclosed package insert provides complete dosage and administration information, as well as directions for syringe usage.*
Digrams-a-b-c (Diagrams A B C)
Father-positive-mother-negative (Father Pos Mother Neg)
Injection (Injected)
Mother-baby (Mother Baby Blk Bgrnd)
Mother-baby (Mother Neg Baby Pos)
Mother-negative (Mother Neg)
Next-pregnancy (Next Pregnancy)
Patient Injection Card (Patientinjectioncard)
HyperRHO" S/D is a form of Rho(D) Immune Globulin (Human) that has been treated with Solvent/Detergent. This is an injectable form of the medication that is used in various medical situations such as antepartum, postpartum, miscarriage, and more. It is important to note that if this medication is used during pregnancy, a patient's baby may test positive for the passive antibody present in the medication. This does not disqualify the patient from receiving the medication again if needed.*
Stay-in-bloodstream (Stay In Bloodstream)
Vial (Vial)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.